Reply to Ganesan et al

Journal of Infectious Diseases

Volumn 205, Issue 3, 2012, Pages 518-519

  Grubb, Jessica R ^a   Overton, Edgar Turner ^b   Presti, Rachel ^a   Önen, Nur F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD38+ T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION; SMOKING HABIT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD; HEPTANOIC ACIDS; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LYMPHOCYTE ACTIVATION; MALE; PYRROLES; RECEPTORS, CCR5; RECEPTORS, CXCR4; RNA, VIRAL; T-LYMPHOCYTES;

EID: 84855902149     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir758     Document Type: Letter

References (9)

1. Ganesan A, Crum-Cianflone N, Higgins J, et al. High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a doubleblind randomized placebo controlled clinical trial. J Infect Dis 2011;203:756-64.
2. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999;179:859-70. (Pubitemid 29159331)
3. Onen NF, Overton ET, Presti R, et al. Suboptimal CD4 recovery on long-term suppressive highly active antiretroviral therapy is associated with favourable outcome. HIV Med 2009;10:439-46.
4. Lane HC. Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation. Top HIV Med 2010;18:2-6.
5. Vital signs: current cigarette smoking among adults aged ≥18 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010;59:1135-40.
6. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008;57:1226-8.
7. Lifson AR, Neuhaus J, Arribas JR, et al. Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial. Am J Public Health 2010;100:1896-903.
8. Feldman JG, Minkoff H, Schneider MF, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006;96:1060-5. (Pubitemid 43825275)
9. Royce RA, Winkelstein W. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS 1990;4:327-33. (Pubitemid 20157015)